NCT01229592

Brief Summary

In recent years, several new methods for treatment of catheter-related bloodstream infections (CRBSI) such as antibiotic or antiseptic lock-therapy have been developed with variable success \[1-10\]. Long-term tunnelled central venous catheters provide a reliable access for administration of chemotherapy, parenteral nutrition or haemodialysis. However, they are not free of complications such as bacteremia. The need to preserve these intra-vascular devices as long as is possible in patients in whom conventional treatment was failed makes emerge antibiotic lock-technique. Ethanol lock-therapy was demonstrate her utility in this cases. But no study has yet been published using the ethanol lock-therapy as a prophylactic therapy in catheter related infections, neither her application in short-term CVCs. Objectives: To investigate the value of a ethanol-lock solution in the prophylaxis of non-tunnelled short-term CVC related infections in a heart post-surgical intensive care unit (HPSICU). Methods: An academic, prospective, randomized and controlled clinical trial is proposed. Patients at HPSICU who have a CVC more than 48 h will be randomized in two arms (ethanol-lock or control group with conventional measurements such as anticoagulants). In the follow-up period, we will register all necessary data to evaluate the end-points of study (CBRSI rate, catheter colonization rate, hospital stay, antimicrobial consume and adverse events due to ethanol).

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2009

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2009

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

October 18, 2010

Completed
10 days until next milestone

First Posted

Study publicly available on registry

October 28, 2010

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2012

Completed
Last Updated

July 17, 2012

Status Verified

July 1, 2012

Enrollment Period

2.2 years

First QC Date

October 18, 2010

Last Update Submit

July 16, 2012

Conditions

Keywords

infectioncatheterbacteriaemiaethanol

Outcome Measures

Primary Outcomes (1)

  • catheter infectionrelated incidence rates

    decrease on catheter infection related incidence rates in comparison to the institution incidence figures

    2 years

Secondary Outcomes (2)

  • cathether bacteriaemia related rate

    2 years

  • antimicrobial consume

    2 years

Study Arms (2)

Ethanol

EXPERIMENTAL

Every three day lock using Ethanol in all the lumen of the Catheter

Drug: Ethanol

Heparine

ACTIVE COMPARATOR

Every three day lock using Heparine in all the lumen of the Catheter

Drug: Heparine

Interventions

Every three day lock using Ethanol(70%)in all the lumen(1ml/per lumen) of the Catheter

Ethanol

Every three day lock using Heparin(Fibrilin TM) 3ml in all the lumen of the Catheter

Heparine

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • older than 18 years old
  • Signed informed consent
  • central Venous catheter more than 48 hours placed

You may not qualify if:

  • pregnancy
  • denial Informed consent Form
  • ethanol intolerance
  • Liver cirrhosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Servicio de Microbiología y Enfermedades Infecciosas. Hospital GU Gregorio Marañon

Madrid, Madrid, 28007, Spain

Location

Related Publications (1)

  • Perez-Granda MJ, Barrio JM, Munoz P, Hortal J, Rincon C, Rabadan PM, Pernia MS, Bouza E. Ethanol lock therapy (E-Lock) in the prevention of catheter-related bloodstream infections (CR-BSI) after major heart surgery (MHS): a randomized clinical trial. PLoS One. 2014 Mar 27;9(3):e91838. doi: 10.1371/journal.pone.0091838. eCollection 2014.

MeSH Terms

Conditions

Catheter-Related InfectionsInfections

Interventions

EthanolHeparin

Intervention Hierarchy (Ancestors)

AlcoholsOrganic ChemicalsGlycosaminoglycansPolysaccharidesCarbohydrates

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 18, 2010

First Posted

October 28, 2010

Study Start

December 1, 2009

Primary Completion

February 1, 2012

Study Completion

February 1, 2012

Last Updated

July 17, 2012

Record last verified: 2012-07

Locations